DiGeorge Syndrome Critical Region Gene 6 (DGCR6) (C-Term) Peptide
-
- Target See all DGCR6 products
- DGCR6 (DiGeorge Syndrome Critical Region Gene 6 (DGCR6))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Western Blotting (WB), Blocking Peptide (BP)
- Sequence
- REEQRAMDQK IVLELDRKVA DQQSTLEKAG VAGFYVTTNP QELMLQMNLL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DGCR6 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DGCR6 (DiGeorge Syndrome Critical Region Gene 6 (DGCR6))
- Synonyms
- AU044152 Peptide, DGCR6 Peptide, DKFZp459P114 Peptide, DGCR6L Peptide, zgc:101841 Peptide, DiGeorge syndrome critical region gene 6 Peptide, protein DGCR6 Peptide, DiGeorge syndrome critical region gene 6 S homeolog Peptide, DGCR6 Peptide, Dgcr6 Peptide, LOC458642 Peptide, dgcr6.S Peptide, dgcr6 Peptide
- Background
-
DiGeorge syndrome, and more widely, the CATCH 22 syndrome, are associated with microdeletions in chromosomal region 22q11.2. The product of this gene shares homology with the Drosophila melanogaster gonadal protein, which participates in gonadal and germ cell development, and with the gamma-1 subunit of human laminin. This gene is a candidate for involvement in DiGeorge syndrome pathology and in schizophrenia.
Protein Size: 220 - Gene ID
- 8214
- NCBI Accession
- NM_005675, NP_005666
- UniProt
- Q14129
-